Reference health
Low-Density Lipoprotein (LDL) Cholesterol is Cross-Sectionally Associated with Preclinical Chronic Kidney Disease (CKD) in Japanese Men
32/32 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 32 checked references that resolve
resolves10.1056/NEJM197403282901301
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
resolves10.1681/ASN.2005010106
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
resolves10.1053/j.ajkd.2006.06.003
Metabolic Syndrome and CKD in a General Japanese Population: The Hisayama Study
resolves10.1291/hypres.30.937
Metabolic Syndrome and Risk of Developing Chronic Kidney Disease in Japanese Adults
resolves10.1681/ASN.V981482
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
resolves10.1046/j.1523-1755.2000.00165.x
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study
resolves10.1046/j.1523-1755.2002.00626.x
Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria
resolves10.1111/j.1464-5491.2006.01858.x
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
resolves10.2337/diabetes.37.12.1595
Banting lecture 1988. Role of insulin resistance in human disease
resolves10.1038/ijo.2008.33
Why metabolic syndrome criteria have not made prime time: a view from the clinic
resolves10.7326/0003-4819-140-3-200402030-00007
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
resolves10.1038/ki.1997.260
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
resolves10.1161/01.HYP.0000190819.07663.da
Body Mass Index and Angiotensin-Dependent Control of the Renal Circulation in Healthy Humans
resolves10.1038/ki.1995.73
Metabolism of low density lipoproteins in nephrotic dyslipidemia: Comparison of hypercholesterolemia alone and combined hyperlipidemia
resolves10.1016/S0021-9150(00)00710-3
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria
resolves10.1152/ajprenal.00099.2005
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
resolves10.2337/dc07-0196
Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study
resolves10.1038/ki.1994.73
Decreased clearance of low-density lipoprotein in patients with chronic renal failure
resolves10.7326/0003-4819-138-2-200301210-00010
Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency
resolves10.1161/01.CIR.0000143892.84582.60
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
resolves10.1016/j.amjcard.2004.10.008
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
resolves10.1016/j.ijcard.2006.06.003
The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: A pooled analysis of double-blind, randomized trials
resolves10.2169/internalmedicine.48.2398
LDL Cholesterol is More Strongly Associated with Metabolic Syndrome in Japanese Women Than in Men
The 3 references without a DOI — listed, not checked
no DOI — not checked2
no DOI — not checked4. Ritz E. Minor renal dysfunction: An emerging independent cardiovascular risk factor. Heart 89: 963-964, 2003.
no DOI — not checked14. World Health Organization. In: Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. World Health Org, Geneva, 1999.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2169/internalmedicine.49.2792"><img src="https://citestamp.com/citestamped/10.2169/internalmedicine.49.2792/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2169/internalmedicine.49.2792)